Dermata raises $2.55M private placement at $1.27/unit with insider participation

Dermata Therapeutics, Inc.

Gross proceeds $2.55M; net ~$2.4M from 2,007,880 shares (or pre-funded warrants) and same number of warrants.
Warrants exercisable at $1.27/share upon stockholder approval and expire five years later.
Insiders (CEO, CFO, board) purchased ~$1.55M of offering at same $1.27/unit price.
Net proceeds plus cash expected to fund operations into Q3 2025.
H.C. Wainwright served as placement agent; resale registration statement to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.